Diagnosis of lupus-like syndrome involves a thorough review of the patient's medical history, including drug and environmental exposure. Laboratory tests may show the presence of antinuclear antibodies (ANA), which are common in autoimmune diseases. However, the specific antibody profile may differ from that seen in true SLE. A key diagnostic criterion is the resolution of symptoms upon discontinuation of the suspected agent.
